⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Branched-Chain Amino Acids (BCAAs)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-30 — Whey protein hydrolysate rich in branched-chain amino acid-containing oligopeptide as a novel nutritional strategy to attenuate age-related muscle weakness.: cross-connection with whey-protein: [animal-model] The aging-mouse comparison links whey formulation to BCAA-containing oligopeptides, but does not establish that free BCAA supplementation reproduces the hydrolysate’s effects or that BCAA content alone explains its advantage. (novelty: 3)
- 2026-09-11 — Divergent amino acid profiles in sarcopenic obesity versus non-obese sarcopenia: A prospective cohort study in community-dwelling older adults.: Prospective community-cohort study in older adults found higher serum BCAAs (and aromatic amino acids) inversely associated with non-obese sarcopenia but positively associated with sarcopenic obesity — opposite-direction associations that argue against uniform amino-acid supplementation across sarcopenia phenotypes. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Divergent amino acid profiles in sarcopenic obesity versus non-obese sarcopenia: A prospective cohort study in community-dwelling older adults.
11-sep-2026
novelty 3
per-area 3
strengthens